197 related articles for article (PubMed ID: 19333146)
1. Improved assay for the nonradioactive determination of inosine 5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cells.
Glander P; Sombogaard F; Budde K; van Gelder T; Hambach P; Liefeldt L; Lorkowski C; Mai M; Neumayer HH; Vulto AG; Mathot RA
Ther Drug Monit; 2009 Jun; 31(3):351-9. PubMed ID: 19333146
[TBL] [Abstract][Full Text] [Related]
2. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.
Vethe NT; Bergan S
Ther Drug Monit; 2006 Oct; 28(5):608-13. PubMed ID: 17038874
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications.
Weimert NA; Derotte M; Alloway RR; Woodle ES; Vinks AA
Ther Drug Monit; 2007 Apr; 29(2):141-9. PubMed ID: 17417067
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of inosin-5'-monophosphate dehydrogenase activity during maintenance therapy with tacrolimus.
Maiguma T; Yosida T; Otsubo K; Okabe Y; Sugitani A; Tanaka M; Oishi R; Teshima D
J Clin Pharm Ther; 2010 Feb; 35(1):79-85. PubMed ID: 20175815
[TBL] [Abstract][Full Text] [Related]
5. Development and application of a high-performance liquid chromatography-based assay for determination of the activity of inosine 5'-monophosphate dehydrogenase in whole blood and isolated mononuclear cells.
Albrecht W; Storck M; Pfetsch E; Martin W; Abendroth D
Ther Drug Monit; 2000 Jun; 22(3):283-94. PubMed ID: 10850395
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatography-coupled tandem mass spectrometry based assay to evaluate inosine-5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cells from stem cell transplant recipients.
Laverdière I; Caron P; Couture F; Guillemette C; Lévesque E
Anal Chem; 2012 Jan; 84(1):216-23. PubMed ID: 22092180
[TBL] [Abstract][Full Text] [Related]
7. Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression.
Bremer S; Mandla R; Vethe NT; Rasmussen I; Rootwelt H; Line PD; Midtvedt K; Bergan S
Transplantation; 2008 Jan; 85(1):55-61. PubMed ID: 18192912
[TBL] [Abstract][Full Text] [Related]
8. Target enzyme activity as a biomarker for immunosuppression.
Glander P; Budde K
Ther Drug Monit; 2010 Jun; 32(3):257-60. PubMed ID: 20431505
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic Monitoring of Mycophenolic Acid Therapy: Improved Liquid Chromatography-Tandem Mass Spectrometry Method for Measuring Inosin-5'-Monophosphate Dehydrogenase Activity.
Weißbarth G; Wiesen MHJ; Fietz C; Streichert T; Ehren R; Weber LT; Müller C
Ther Drug Monit; 2020 Apr; 42(2):282-288. PubMed ID: 31425491
[TBL] [Abstract][Full Text] [Related]
10. Non-radioactive determination of inosine 5'-monophosphate dehydro-genase (IMPDH) in peripheral mononuclear cells.
Glander P; Braun KP; Hambach P; Bauer S; Mai I; Roots I; Waiser J; Fritsche L; Neumayer HH; Budde K
Clin Biochem; 2001 Oct; 34(7):543-9. PubMed ID: 11738390
[TBL] [Abstract][Full Text] [Related]
11. Optimization and application of an HPLC method for quantification of inosine-5'-monophosphate dehydrogenase activity as a pharmacodynamic biomarker of mycophenolic acid in Chinese renal transplant patients.
Liu F; Xu L; Sheng C; Qiu X; Zhang M; Jiao Z
Clin Chim Acta; 2018 Oct; 485():333-339. PubMed ID: 29964005
[TBL] [Abstract][Full Text] [Related]
12. Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acid.
Rother A; Glander P; Vitt E; Czock D; von Ahsen N; Armstrong VW; Oellerich M; Budde K; Feneberg R; Tönshoff B; Weber LT
Eur J Clin Pharmacol; 2012 Jun; 68(6):913-22. PubMed ID: 22274404
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic monitoring of mycophenolate mofetil.
Budde K; Glander P; Bauer S; Braun K; Waiser J; Fritsche L; Mai I; Roots I; Neumayer HH
Clin Chem Lab Med; 2000 Nov; 38(11):1213-6. PubMed ID: 11156363
[TBL] [Abstract][Full Text] [Related]
14. Inosine monophosphate dehydrogenase (IMPDH) activity as a pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipients.
Fukuda T; Goebel J; Thøgersen H; Maseck D; Cox S; Logan B; Sherbotie J; Seikaly M; Vinks AA
J Clin Pharmacol; 2011 Mar; 51(3):309-20. PubMed ID: 20418509
[TBL] [Abstract][Full Text] [Related]
15. Plasma and intracellular pharmacokinetic-pharmacodynamic analysis of mycophenolic acid in de novo kidney transplant patients.
Thi MT; Mourad M; Capron A; Tshinanu FM; Vincent MF; Wallemacq P
Clin Biochem; 2015 Apr; 48(6):401-5. PubMed ID: 25523299
[TBL] [Abstract][Full Text] [Related]
16. Multicenter evaluation of a new inosine monophosphate dehydrogenase inhibition assay for quantification of total mycophenolic acid in plasma.
Brandhorst G; Marquet P; Shaw LM; Liebisch G; Schmitz G; Coffing MJ; Domke I; Streit F; Luthe H; Oellerich M
Ther Drug Monit; 2008 Aug; 30(4):428-33. PubMed ID: 18641549
[TBL] [Abstract][Full Text] [Related]
17. Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy.
Chiarelli LR; Molinaro M; Libetta C; Tinelli C; Cosmai L; Valentini G; Dal Canton A; Regazzi M
Br J Clin Pharmacol; 2010 Jan; 69(1):38-50. PubMed ID: 20078611
[TBL] [Abstract][Full Text] [Related]
18. Influence of mycophenolic acid on inosine 5'-monophosphate dehydrogenase activity in human peripheral blood mononuclear cells.
Daxecker H; Raab M; Müller MM
Clin Chim Acta; 2002 Apr; 318(1-2):71-7. PubMed ID: 11880114
[TBL] [Abstract][Full Text] [Related]
19. Inosine 5'-Monophosphate Dehydrogenase Activity for the Longitudinal Monitoring of Mycophenolic Acid Treatment in Kidney Allograft Recipients.
Glander P; Waiser J; Hambach P; Bachmann F; Budde K; Eckardt KU; Friedersdorff F; Gaedeke J; Kron S; Lorkowski C; Mai M; Neumayer HH; Peters R; Rudolph B; Schmidt D; Wu K; Liefeldt L
Transplantation; 2021 Apr; 105(4):916-927. PubMed ID: 32496356
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of inosine monophosphate dehydrogenase activity in mononuclear cells of children with acute lymphoblastic leukemia: enzymological and clinical aspects.
Brouwer C; Vermunt-de Koning DG; Trueworthy RC; Ter Riet PG; Duley JA; Trijbels FJ; Hoogerbrugge PM; Bökkerink JP; van Wering ER; De Abreu RA
Pediatr Blood Cancer; 2006 Apr; 46(4):434-8. PubMed ID: 16333815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]